INFLUENCE OF AKT1, AKT2 AND FRAP1 POLYMORPHISMS ON RESPONSE AND SURVIVAL IN HEAD AND NECK CANCER (SCCHN) PATIENTS TREATED WITH DOCETAXEL AND CETUXIMAB

被引：0
|
作者：
Pfisterer, K. [1 ]
Klinghammer, K. [1 ]
Fusi, A. [1 ]
Knoedler, M. [1 ]
Nonnenmacher, A. [1 ]
Keilholz, U. [1 ]
机构：
[1] Charite CBF, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [41] PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel
    Pfisterer, Katharina
    Fusi, Alberto
    Klinghammer, Konrad
    Knoedler, Maren
    Nonnenmacher, Anika
    Keilholz, Ulrich
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (04): : 471 - 478
  • [42] Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation (vol 107, pg 2598, 2010)
    Ericson, Kajsa
    Gan, Christine
    Cheong, Ian
    Rago, Carlo
    Samuels, Yardena
    Velculescu, Victor E.
    Kinzler, Kenneth W.
    Huso, David L.
    Vogelstein, Bert
    Papadopoulos, Nickolas
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (14) : 6551 - 6551
  • [43] Monalizumab in combination with cetuximab in patients (pts) with recurrent or metastatic (R/M) head and neck cancer (SCCHN) previously treated or not with PD-(L)1 inhibitors (IO): 1-year survival data
    Cohen, R. B.
    Lefebvre, G.
    Posner, M. R.
    Bauman, J. R.
    Salas, S.
    Even, C.
    Saada-Bouzid, E.
    Seiwert, T.
    Colevas, D.
    Calmels, F.
    Zerbib, R.
    Andre, P.
    Boyer-Chammard, A.
    Fayette, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 460 - 460
  • [44] Divergent activation of AKT1 and AKT2 isoforms downstream of PI3K mutation impacts response of breast cancer cells to estradiol and PI3K inhibitors
    Nakshatri, Harikrishna
    Goswami, Chirayu
    Badve, Sunil
    Magnani, Luca
    Lupien, Mathieu
    Bhat-Nakshatri, Poornima
    CANCER RESEARCH, 2015, 75
  • [45] Inhibition of Hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells
    Shearn, Colin T.
    Reigan, Philip
    Petersen, Dennis R.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (01) : 1 - 11
  • [46] AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines
    Koseoglu, Sandra
    Lu, Zhuomei
    Kumar, Chandra
    Kirschmeier, Paul
    Zou, Jun
    CANCER BIOLOGY & THERAPY, 2007, 6 (05) : 755 - 762
  • [47] Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
    de Nobrega, Monyse
    Ciliao, Heloisa Lizotti
    de Souza, Marilesia Ferreira
    de Souza, Milene Roldao
    Serpeloni, Juliana Mara
    Fuganti, Paulo Emilio
    de Syllos Colus, Ilce Mara
    GENETICS AND MOLECULAR BIOLOGY, 2020, 43 (03)
  • [48] Polymorphisms in AKT1 and EGFR as possible new biomarkers of clinical outcome and toxicity in non-small-cell lung cancer patients treated with gefitinib
    Giovannetti, E.
    Zucali, P.
    Tibaldi, C.
    Smit, E.
    Falcone, A.
    Santoro, A.
    Leon, L.
    Giaccone, G.
    Danesi, R.
    Peters, G.
    EJC SUPPLEMENTS, 2009, 7 (04): : 9 - 9
  • [49] Depletion of PCAT1 in head and neck cancer cells limits tumor growth by regulating c-Myc, AKT1 and MAPK signalling pathways
    Sur, Subhayan
    Steele, Robert
    Ray, Ratna B.
    CANCER RESEARCH, 2019, 79 (13)
  • [50] Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
    Bouhaddou, Mehdi
    Lee, Rex H.
    Li, Hua
    Bhola, Neil E.
    O'Keefe, Rachel A.
    Naser, Mohammad
    Zhu, Tian Ran
    Nwachuku, Kelechi
    Duvvuri, Umamaheswar
    Olshen, Adam B.
    Roy, Ritu
    Hechmer, Aaron
    Bolen, Jennifer
    Keysar, Stephen B.
    Jimeno, Antonio
    Mills, Gordon B.
    Vandenberg, Scott
    Swaney, Danielle L.
    Johnson, Daniel E.
    Krogan, Nevan J.
    Grandis, Jennifer R.
    JCI INSIGHT, 2021, 6 (20)
12345